Mylan N.V. (MYL) Misses Q2 EPS by 15c, Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Mylan N.V. (MYL) Misses Q2 EPS by 15c, Guidance Misses
August 8, 2018 8:31 AM EDT
HERTFORDSHIRE, England, Aug. 8, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.'s (NASDAQ: MYL) board of directors today released the following statement:
Over the past decade, Mylan's Board of Directors and management team have turned Mylan into a leading global platform with a highly-diversified portfolio of products across broad therapeutic areas and geographies. Our long-term strategy and management's continued execution have consistently served the best interests of all of our stakeholders.
Our international business, in which we expect continued growth, now represents more than 60% of the company's global... More
August 8, 2018 8:31 AM EDT
HERTFORDSHIRE, England and PITTSBURGH, Aug. 8, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the quarter and six months ended June 30, 2018.
Second Quarter 2018 Financial Highlights
Total revenues of $2.81 billion, down 5% compared to the prior year period.
Rest of World segment net sales of $764.1 million, up 10%, up 11% on a constant currency basis.
Europe segment net sales of $990.6 million, up 4%, down 3% on...
More
